• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Model Number RRT06060080L
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Ischemia (1942)
Event Date 08/12/2019
Event Type  Injury  
Manufacturer Narrative
Device evaluated by manufacturer: other code - the medical device returned to a third party for investigation.The analysis report was shared with gore and evaluated appropriately.The investigation is still ongoing.The results will be included in the final report.
 
Event Description
It was reported to gore that patient underwent endovascular treatment on (b)(6) 2019 for a femoro-anterio-tibial bypass (extra-anatomic) in order to treat a highly advanced right limb critical ischemia, with superinfected major trophic disorders, by using a gore-tex® vascular graft - thin-walled removable ringed.It was stated that the bypass thrombosed rapidly and in front of the very important trophic disorders (painful and superinfected) and despite revascularization, it was decided to perform a thigh amputation three days later.Reportedly, the prosthesis was sent for analysis.
 
Manufacturer Narrative
H6 evaluation codes investigation findings 213 refers to the phr-review.Phr-review: a review of the manufacturing records indicated the lot met all pre-release specifications.A review of the boxing records indicated the lot met all pre-release specifications.Explant investigation (ei): the following is a summary of the ei observations: tissue present: no.The device fragment was generally devoid of tissue, except for an area of dark brown and tan tissue present on the abluminal surface, near extremity a.A small-bore fragment of the native vessel was attached to extremity a via blue sutures (presumptive anastomotic site).The lumen at extremity a was unobservable with the images provided.The luminal view from extremity b was partially obstructed with white/tan tissue.Lumen patency could not be determined with the images provided.A smooth-edge, partial, transverse transection was present on the graft fragment, near extremity b.Extremity b was transected, ovular in shape, and presented with smooth edges.The transections were consistent with those caused by sharp surgical instrumentation (i.E., scalpel, scissors), likely used during a surgical procedure.Request for additional analysis: no.Reason: material disruptions are consistent with those caused by surgical instrumentation during the explant process.Based on the ei¿s review of the third party report, no additional analysis is requested.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Manufacturer Narrative
H6 evaluation codes investigation conclusions was updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10620266
MDR Text Key209613536
Report Number3003910212-2020-01107
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132610945
UDI-Public00733132610945
Combination Product (y/n)N
PMA/PMN Number
K880167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 09/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/30/2024
Device Model NumberRRT06060080L
Device Catalogue NumberRRT06060080L
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/08/2020
Initial Date FDA Received10/02/2020
Supplement Dates Manufacturer Received05/06/2021
09/14/2021
Supplement Dates FDA Received05/25/2021
09/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age72 YR
-
-